CROs offering Protein Engineering with Biologics (Monoclonal Antibodies)
11 published
11 published CROs match Protein Engineering and Biologics (Monoclonal Antibodies).
Locations in this set include China, United States, Netherlands, South Korea, Australia, and Denmark.
Capabilities that show up most often in this set: Discovery Research, In Vitro Pharmacology, Analytical Method Development & Validation, Bioanalysis, and Computational & In-Silico Drug Discovery.
Matching companies
- Accelagen, Inc.Accelagen is a Gene-to-Protein company providing protein expression, purification, and molecular biology services across baculovirus, mammalian, and E. coli systems.
Alloy TherapeuticsProduct development organization offering AI/ML-driven antibody and multispecific discovery, TCR mimic (TCRm) discovery, and antisense oligonucleotide design, backed by transgenic mouse platforms and pharmacology studies.
Aragen Life SciencesGlobal CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
AvantGen, Inc.AvantGen is a contract antibody discovery and engineering partner offering proprietary yeast display platforms for discovery, optimization, and development of novel antibody drugs.
ChemPartnerGlobal preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide.
ProBioProBio is a leading global CDMO subsidiary of GenScript Biotech Corporation, providing end-to-end services for biologics and cell & gene therapy (CGT) from drug discovery through commercialization.
Proone LabsProone Labs provides preclinical pharmacology, drug discovery, and regulatory support services to biotech startups, traditional pharma, and in-silico companies. The team has delivered 30+ assays, 50+ cell lines, and supported 4 FDA drug approvals across multiple therapeutic areas.
Qoolabs, IncQoolabs specializes in rapid rabbit monoclonal antibody development using the QMAb™ platform, delivering highly specific antibodies with natural heavy-light chain pairing in 3–4 months from immunization.
Rapid Novor Inc.Rapid Novor is a contract research organization specializing in antibody discovery, characterization, and sequencing services powered by mass spectrometry, HDX-MS, and surface plasmon resonance.
SelvitaSelvita is an integrated drug discovery and development service provider offering comprehensive solutions from target validation through preclinical candidate nomination and clinical manufacturing, with expertise in small molecules, antibodies, and protein degraders.
WuXi AppTecGlobal CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.
Markdown mirror: /explore/protein-engineering/biologics-monoclonal-antibodies.md